- Home
- BCYC vs BETR Comparison
BCYC vs BETR Comparison
Compare BCYC & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCYC | BETR |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 538.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCYC | BETR |
|---|---|---|
| Price | $5.09 | $35.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 1 |
| Target Price | $13.90 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 574.3K | 539.8K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $54.06 |
| Revenue Next Year | N/A | $66.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.24 | $10.81 |
| 52 Week High | $9.55 | $94.06 |
Technical Indicators
Market Signals| Indicator | BCYC | BETR |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 51.57 |
| Support Level | $5.03 | $26.89 |
| Resistance Level | $5.90 | $35.07 |
| Average True Range (ATR) | 0.26 | 3.39 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 75.68 | 33.23 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.